<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35403516</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1521-0464</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>29</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Drug delivery</Title>
          <ISOAbbreviation>Drug Deliv</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Hyaluronan-modified transfersomes based hydrogel for enhanced transdermal delivery of indomethacin.</ArticleTitle>
        <Pagination>
          <StartPage>1232</StartPage>
          <EndPage>1242</EndPage>
          <MedlinePgn>1232-1242</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/10717544.2022.2053761</ELocationID>
        <Abstract>
          <AbstractText>Hyaluronic acid (HA), as a hygroscopic and biocompatible molecule, has displayed unique permeation enhancement in transdermal delivery systems. Hence, indomethacin (IND) was encapsulated in HA-modified transfersomes (IND-HTs) to enhance transdermal IND delivery to reduce adverse effects in this study. The physiochemical properties of IND-HTs were characterized. Results showed that the prepared IND-HTs were spherical and revealed good entrapment efficiency (87.88 ± 2.03%), with a nanometric particle size (221.8 ± 93.34 nm). Then, IND-HTs were further incorporated into a carbopol 940 hydrogel (IND-HTs/Gel) to prolong retention capacity on the skin. The <i>in vitro</i> release and skin permeation experiments of IND-HTs/Gel were carried out with the Franz diffusion cells. It was found that IND-HTs/Gel exhibited sustained drug release, as well as superior drug permeation and flux across the skin. Confocal laser scanning microscopy showed improved penetration of HTs/Gel with a wider distribution and higher fluorescence intensity. The hematoxylin-eosin stained showed that HA improved the transdermal effect by changing the microstructure of skin layers and decreasing skin barrier function. In addition, IND-HTs/Gel showed significant analgesic activity in hot plate test and no potentially hazardous skin irritation. This study indicated that the developed IND-HTs/Gel could be a promising alternative to conventional oral delivery of IND by topical administration.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yuan</LastName>
            <ForeName>Ming</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>College of Food and Drug, Henan Functional Cosmetics Engineering &amp; Technology Research Center, Luoyang Normal University, Luoyang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Niu</LastName>
            <ForeName>Jiangxiu</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>College of Food and Drug, Henan Functional Cosmetics Engineering &amp; Technology Research Center, Luoyang Normal University, Luoyang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiao</LastName>
            <ForeName>Qinghan</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>College of Food and Drug, Henan Functional Cosmetics Engineering &amp; Technology Research Center, Luoyang Normal University, Luoyang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ya</LastName>
            <ForeName>Huiyuan</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>College of Food and Drug, Henan Functional Cosmetics Engineering &amp; Technology Research Center, Luoyang Normal University, Luoyang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Yansong</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>College of Food and Drug, Henan Functional Cosmetics Engineering &amp; Technology Research Center, Luoyang Normal University, Luoyang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fan</LastName>
            <ForeName>Yanli</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>College of Food and Drug, Henan Functional Cosmetics Engineering &amp; Technology Research Center, Luoyang Normal University, Luoyang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Lingmei</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>College of Food and Drug, Henan Functional Cosmetics Engineering &amp; Technology Research Center, Luoyang Normal University, Luoyang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Xueke</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>College of Food and Drug, Henan Functional Cosmetics Engineering &amp; Technology Research Center, Luoyang Normal University, Luoyang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Drug Deliv</MedlineTA>
        <NlmUniqueID>9417471</NlmUniqueID>
        <ISSNLinking>1071-7544</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004337">Drug Carriers</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D020100">Hydrogels</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9004-61-9</RegistryNumber>
          <NameOfSubstance UI="D006820">Hyaluronic Acid</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>XXE1CET956</RegistryNumber>
          <NameOfSubstance UI="D007213">Indomethacin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000279" MajorTopicYN="N">Administration, Cutaneous</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004337" MajorTopicYN="N">Drug Carriers</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016503" MajorTopicYN="N">Drug Delivery Systems</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006820" MajorTopicYN="Y">Hyaluronic Acid</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020100" MajorTopicYN="N">Hydrogels</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007213" MajorTopicYN="Y">Indomethacin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010316" MajorTopicYN="N">Particle Size</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012869" MajorTopicYN="N">Skin Absorption</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Transdermal drug delivery</Keyword>
        <Keyword MajorTopicYN="N">hyaluronan</Keyword>
        <Keyword MajorTopicYN="N">hydrogel</Keyword>
        <Keyword MajorTopicYN="N">indomethacin</Keyword>
        <Keyword MajorTopicYN="N">transfersome</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>11</Day>
          <Hour>8</Hour>
          <Minute>43</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35403516</ArticleId>
        <ArticleId IdType="pmc">PMC9004534</ArticleId>
        <ArticleId IdType="doi">10.1080/10717544.2022.2053761</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Abd El-Alim SH, Kassem AA, Basha M, et al.  (2019). Comparative study of liposomes, ethosomes and transfersomes as carriers for enhancing the transdermal delivery of diflunisal: in vitro and in vivo evaluation. Int J Pharm
563:293–303.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30951860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alkilani AZ, McCrudden MT, Donnelly RF. (2015). Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics
7:438–70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4695828</ArticleId>
            <ArticleId IdType="pubmed">26506371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andrews SN, Jeong E, Prausnitz MR. (2013). Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum. Pharm Res
30:1099–109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3596453</ArticleId>
            <ArticleId IdType="pubmed">23196771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ascenso A, Raposo S, Batista C, et al.  (2015). Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes. Int J Nanomedicine
10:5837–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4583114</ArticleId>
            <ArticleId IdType="pubmed">26425085</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aziz ZAA, Nasir HM, Ahmad A, et al.  (2019). Enrichment of Eucalyptus oil nanoemulsion by micellar nanotechnology: transdermal analgesic activity using hot plate test in rats' assay. Sci Rep
9:13678.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6757054</ArticleId>
            <ArticleId IdType="pubmed">31548590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Badri W, Miladi K, Robin S, et al.  (2017). Polycaprolactone based nanoparticles loaded with indomethacin for anti-inflammatory therapy: from preparation to ex vivo study. Pharm Res
34:1773–83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28527126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Balzus B, Colombo M, Sahle FF, et al.  (2016). Comparison of different in vitro release methods used to investigate nanocarriers intended for dermal application. Int J Pharm
513:247–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27628784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batool S, Zahid F, Ud-Din F, et al.  (2021). Macrophage targeting with the novel carbopol-based miltefosine-loaded transfersomal gel for the treatment of cutaneous leishmaniasis: in vitro and in vivo analyses. Drug Dev Ind Pharm
47:440–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33615936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cilurzo F, Vistoli G, Gennari CG, et al.  (2014). The role of the conformational profile of polysaccharides on skin penetration: the case of hyaluronan and its sulfates. Chem Biodivers
11:551–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24706625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Oliveira EL, Ferreira SBS, de Castro-Hoshino LV, et al.  (2021). Thermoresponsive hydrogel-loading aluminum chloride phthalocyanine as a drug release platform for topical administration in photodynamic therapy. Langmuir
37:3202–13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33682407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Leithy ES, Ibrahim HK, Sorour RM. (2015). In vitro and in vivo evaluation of indomethacin nanoemulsion as a transdermal delivery system. Drug Deliv
22:1010–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24188427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guermech I, Lassoued MA, Abdelhamid A, et al.  (2019). Development and assessment of lipidic nanoemulsions containing sodium hyaluronate and indomethacin. AAPS PharmSciTech
20:330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31677079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khan AU, Jamshaid H, Ud Din F, et al.  (2022). Designing, optimization and characterization of trifluralin transfersomal gel to passively target cutaneous leishmaniasis. J Pharm Sci;</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">35081406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kilfoyle BE, Sheihet L, Zhang Z, et al.  (2012). Development of paclitaxel-TyroSpheres for topical skin treatment. J Control Release
163:18–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3462247</ArticleId>
            <ArticleId IdType="pubmed">22732474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laurent TC, Fraser JR. (1992). Hyaluronan. FASEB J
6:2397–404.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1563592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lenz E, Jensen KT, Blaabjerg LI, et al.  (2015). Solid-state properties and dissolution behaviour of tablets containing co-amorphous indomethacin–arginine. Eur J Pharm Biopharm
96:44–52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26197392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li ZL, Peng SF, Chen X, et al.  (2018). Pluronics modified liposomes for curcumin encapsulation: sustained release, stability and bioaccessibility. Food Res Int
108:246–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29735054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li H, Peng Q, Guo Y, et al.  (2020). Preparation and in vitro and in vivo study of asiaticoside-loaded nanoemulsions and nanoemulsions-based gels for transdermal delivery. Int J Nanomedicine
15:3123–36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7210032</ArticleId>
            <ArticleId IdType="pubmed">32440114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maestrelli F, Gonzalez-Rodriguez ML, Rabasco AM, et al.  (2010). New "drug-in cyclodextrin-in deformable liposomes" formulations to improve the therapeutic efficacy of local anaesthetics. Int J Pharm
395:222–31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20594944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mishra R, Prabhavalkar KS, Bhatt LK. (2016). Preparation, optimization, and evaluation of zaltoprofen-loaded microemulsion and microemulsion-based gel for transdermal delivery. J Liposome Res
26:297–306.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26785055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mura P, Maestrelli F, Gonzalez-Rodriguez ML, et al.  (2007). Development, characterization and in vivo evaluation of benzocaine-loaded liposomes. Eur J Pharm Biopharm
67:86–95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17350813</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niu J, Yuan M, Chen C, et al.  (2020). Berberine-loaded thiolated Pluronic F127 polymeric micelles for improving skin permeation and retention. Int J Nanomedicine
15:9987–10005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7733396</ArticleId>
            <ArticleId IdType="pubmed">33324058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Penoy N, Grignard B, Evrard B, et al.  (2021). A supercritical fluid technology for liposome production and comparison with the film hydration method. Int J Pharm
592:120093.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33212171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Puglia C, Trombetta D, Venuti V, et al.  (2004). Evaluation of in-vivo topical anti-inflammatory activity of indometacin from liposomal vesicles. J Pharm Pharmacol
56:1225–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15482636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pukale SS, Sharma S, Dalela M, et al.  (2020). Multi-component clobetasol-loaded monolithic lipid-polymer hybrid nanoparticles ameliorate imiquimod-induced psoriasis-like skin inflammation in Swiss albino mice. Acta Biomater
115:393–409.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32846238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qindeel M, Ullah MH, Fakhar UD, et al.  (2020). Recent trends, challenges and future outlook of transdermal drug delivery systems for rheumatoid arthritis therapy. J Control Release
327:595–615.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32920080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rabia S, Khaleeq N, Batool S, et al.  (2020). Rifampicin-loaded nanotransferosomal gel for treatment of cutaneous leishmaniasis: passive targeting via topical route. Nanomedicine
15:183–203.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31916472</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saboo S, Kestur US, Flaherty DP, et al.  (2020). Congruent release of drug and polymer from amorphous solid dispersions: insights into the role of drug–polymer hydrogen bonding, surface crystallization, and glass transition. Mol Pharm
17:1261–75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32134677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sala M, Diab R, Elaissari A, et al.  (2018). Lipid nanocarriers as skin drug delivery systems: properties, mechanisms of skin interactions and medical applications. Int J Pharm
535:1–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29111097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salim MW, Shabbir K, ud-Din F, et al.  (2020). Preparation, in-vitro and in-vivo evaluation of rifampicin and vancomycin co-loaded transfersomal gel for the treatment of cutaneous leishmaniasis. J Drug Deliv Sci Technol
60:101996.</Citation>
        </Reference>
        <Reference>
          <Citation>Singh D, Pradhan M, Nag M, et al.  (2015). Vesicular system: versatile carrier for transdermal delivery of bioactives. Artif Cells Nanomed Biotechnol
43:282–90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24564350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Son SU, Lim JW, Kang T, et al.  (2017). Hyaluronan-based nanohydrogels as effective carriers for transdermal delivery of lipophilic agents: towards transdermal drug administration in neurological disorders. Nanomaterials
7:427.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5746917</ArticleId>
            <ArticleId IdType="pubmed">29207551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song L, Pan Z, Zhang H, et al.  (2017). Dually folate/CD44 receptor-targeted self-assembled hyaluronic acid nanoparticles for dual-drug delivery and combination cancer therapy. J Mater Chem B
5:6835–46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32264333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Surini S, Leonyza A, Suh CW. (2020). Formulation and in vitro penetration study of recombinant human epidermal growth factor-loaded transfersomal emulgel. Adv Pharm Bull
10:586–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7539322</ArticleId>
            <ArticleId IdType="pubmed">33072536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tan G, Xu P, Lawson LB, et al.  (2010). Hydration effects on skin microstructure as probed by high-resolution cryo-scanning electron microscopy and mechanistic implications to enhanced transcutaneous delivery of biomacromolecules. J Pharm Sci
99:730–40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2849273</ArticleId>
            <ArticleId IdType="pubmed">19582754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Touitou E, Dayan N, Bergelson L, et al.  (2000). Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release
65:403–18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10699298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Wang S, Shi P. (2016). Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy. Drug Deliv
23:3193–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27045388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang JA, Kim ES, Kwon JH, et al.  (2012). Transdermal delivery of hyaluronic acid – human growth hormone conjugate. Biomaterials
33:5947–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22632765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang W, Xu H, Lan Y, et al.  (2019). Preparation and characterisation of a novel silk fibroin/hyaluronic acid/sodium alginate scaffold for skin repair. Int J Biol Macromol
130:58–67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30797808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yassin NZ, El-Shenawy SM, Abdel-Rahman RF, et al.  (2015). Effect of a topical copper indomethacin gel on inflammatory parameters in a rat model of osteoarthritis. Drug Des Devel Ther
9:1491–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4362896</ArticleId>
            <ArticleId IdType="pubmed">25792809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Ng W, Hu J, et al.  (2018). Formulation and in vitro stability evaluation of ethosomal carbomer hydrogel for transdermal vaccine delivery. Colloids Surf B Biointerfaces
163:184–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29294420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Xia Q, Li Y, et al.  (2019). CD44 assists the topical anti-psoriatic efficacy of curcumin-loaded hyaluronan-modified ethosomes: a new strategy for clustering drug in inflammatory skin. Theranostics
9:48–64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6332788</ArticleId>
            <ArticleId IdType="pubmed">30662553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang ZJ, Osmałek T, Michniak-Kohn B. (2020). Deformable liposomal hydrogel for dermal and transdermal delivery of meloxicam. Int J Nanomedicine
15:9319–35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7700092</ArticleId>
            <ArticleId IdType="pubmed">33262590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu J, Tang X, Jia Y, et al.  (2020). Applications and delivery mechanisms of hyaluronic acid used for topical/transdermal delivery – a review. Int J Pharm
578:119127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32036009</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
